Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/3697
Title: | Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment |
Authors: | Laborda-Illanes, Aurora Sanchez-Alcoholado, Lidia Dominguez-Recio, María Emilia Jimenez-Rodriguez, Begoña Lavado, Rocío Comino-Méndez, Iñaki Alba, Emilio Queipo-Ortuño, María Isabel |
metadata.dc.contributor.authoraffiliation: | [Laborda-Illanes,A; Sanchez-Alcoholado,L; Dominguez-Recio,ME; Jimenez-Rodriguez,B; Lavado,R; Comino-Méndez,I; Alba,E; Queipo-Ortuño,MI] Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA)-CIMES-UMA, Málaga, Spain. [Laborda-Illanes,A; Sanchez-Alcoholado,L] Facultad de Medicina, Universidad de Málaga, Málaga, Spain. |
Keywords: | Breast cancer;Microbiota;Estrobolome;Immune responds;Inflammation;Epigenetic modulation;Anticancer therapy;Prebiotics;Probiotics;Neoplasias de la mama;Inmunidad;Inflamación;Epigénesis genética;Antineoplásicos;Prebióticos;Probióticos |
metadata.dc.subject.mesh: | Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms Medical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Microbiota Medical Subject Headings::Phenomena and Processes::Immune System Phenomena::Immunity Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Epigenesis, Genetic Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Polysaccharides::Polysaccharides, Bacterial::Prebiotics Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Dysbiosis Medical Subject Headings::Technology and Food and Beverages::Food and Beverages::Food::Dietary Supplements Medical Subject Headings::Phenomena and Processes::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproductive Physiological Processes::Sexual Development::Climacteric::Menopause::Postmenopause Medical Subject Headings::Check Tags::Female Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors |
Issue Date: | 31-Aug-2020 |
Publisher: | MDPI |
Citation: | Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, et al. Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment. Cancers. 2020 Aug 31;12(9):2465 |
Abstract: | In breast cancer (BC) the employment of sequencing technologies for metagenomic analyses has allowed not only the description of the overall metagenomic landscape but also the specific microbial changes and their functional implications. Most of the available data suggest that BC is related to bacterial dysbiosis in both the gut microenvironment and breast tissue. It is hypothesized that changes in the composition and functions of several breast and gut bacterial taxa may contribute to BC development and progression through several pathways. One of the most prominent roles of gut microbiota is the regulation of steroid-hormone metabolism, such as estrogens, a component playing an important role as risk factor in BC development, especially in postmenopausal women. On the other hand, breast and gut resident microbiota are the link in the reciprocal interactions between cancer cells and their local environment, since microbiota are capable of modulating mucosal and systemic immune responses. Several in vivo and in vitro studies show remarkable evidence that diet, probiotics and prebiotics could exert important anticarcinogenic effects in BC. Moreover, gut microbiota have an important role in the metabolism of chemotherapeutic drugs and in the activity of immunogenic chemotherapies since they are a potential dominant mediator in the response to cancer therapy. Then, the microbiome impact in BC is multi-factorial, and the gut and breast tissue bacteria population could be important in regulating the local immune system, in tumor formation and progression and in therapy response and/or resistance. |
URI: | http://hdl.handle.net/10668/3697 |
metadata.dc.relation.publisherversion: | https://www.mdpi.com/2072-6694/12/9/2465/htm |
metadata.dc.identifier.doi: | 10.3390/cancers12092465 |
ISSN: | 2072-6694 (Online) |
Appears in Collections: | 01- Artículos - Hospital Regional de Málaga 01- Artículos - Hospital Virgen de la Victoria 01- Artículos - IBIMA. Instituto de Investigación Biomédica de Málaga |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
LabordaIllanes_BreastAndGut.pdf | Revisión | 1,31 MB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License